Back to MORGAN STANLEY MORGAN STANLEY

TXGTXG
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in 10x Genomics Inc Class A

MORGAN STANLEY holds 3.4M shares of TXG (10x Genomics Inc Class A), worth $128.5M as of 2026-Q2. The position was increased (+26.2% shares). TXG represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$128.5M

Current Shares

3.4M

Total Value Change

+$16.2M

Total Shares Change

-2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.4M
+26.2%
$128.5M0.0%$38.34
37
2026-Q1
Decreased
2.7M
-16.9%
$56.4M0.0%$22.62
0
2025-Q4
Increased
3.2M
+13.5%
$52.1M0.0%$16.29
33
2025-Q3
Decreased
2.8M
-19.2%
$32.9M0.0%$11.34
0
2025-Q2
Increased
3.5M
+25.7%
$40.4M0.0%$11.73
36
2025-Q1
Decreased
2.8M
-29.3%
$24.2M0.0%$9.16
0
2024-Q4
Decreased
3.9M
-39.4%
$56.4M0.0%$14.35
0
2024-Q3
Increased
6.5M
+12.2%
$146.2M0.0%$22.67
34
2024-Q2
New
5.8M
-
$112.3M0.0%$19.45
42

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used